Miriam M. Yeung

Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

Omer Gilan, Inmaculada Rioja, Kathy Knezevic et al. · Science · 2020 · 428 citations · Full text

Life Sciences, Immunology, Pharmacology +13

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

Charles C. Bell, Katie Fennell, Yih-Chih Chan et al. · Nature Communications · 2019 · 180 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

HBO1 is required for the maintenance of leukaemia stem cells

Laura MacPherson, Juliana Anokye, Miriam M. Yeung et al. · Nature · 2019 · 174 citations · Full text

Life Sciences, Cell Biology, Hematology +11

A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer

Sheau Wen Lok, James R. Whittle, François Vaillant et al. · Cancer Discovery · 2019 · 145 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults

Nila J. Dharan, Paul Yeh, Mark Bloch et al. · Nature Medicine · 2021 · 104 citations

Medicine, Hematology, Infectious Diseases +10